ERBB2 and cancer: ssDNA aptamers to HER-2 have recently been selected through a hybrid-SELEX [109], combining 8 rounds a protein-SELEX using the His-tagged extracellular domain of HER-2 and 7 rounds of cell-SELEX on HER-2 over-expressed in SKOV3 cancer cells.